SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34134766/

doi: 10.1186/s40364-021-00296-7. 1 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. 2 Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. 3 Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. [email protected]. 4 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.